Respiratory Syncytial Virus mRNA Vaccine(Inventprise)(Respiratory Syncytial Virus mRNA Vaccine(Inventprise))

概要

基本信息

药物类型

预防性疫苗、mRNA疫苗

别名

mRNA RSV(Inventprise)

靶点-

作用方式-

作用机制-

治疗领域

感染

在研适应症

呼吸道合胞体病毒感染

非在研适应症-

原研机构

Inventprise, Inc.

在研机构

Inventprise, Inc.

非在研机构-

最高研发阶段临床前

首次获批日期-

最高研发阶段(中国)-

特殊审评-

关联

100 项与 Respiratory Syncytial Virus mRNA Vaccine(Inventprise) 相关的临床结果

登录后查看更多信息

100 项与 Respiratory Syncytial Virus mRNA Vaccine(Inventprise) 相关的转化医学

登录后查看更多信息

100 项与 Respiratory Syncytial Virus mRNA Vaccine(Inventprise) 相关的专利（医药）

登录后查看更多信息

2

项与 Respiratory Syncytial Virus mRNA Vaccine(Inventprise) 相关的文献（医药）

2025-04-01·Hospital Pharmacy

Respiratory Syncytial Virus Vaccine (mRNA)

Review

作者: Levien, Terri L. ; Baker, Danial E.

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy and Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

American Journal of Health-System Pharmacy

Respiratory Syncytial Virus Vaccine (mRNA)

Article

100 项与 Respiratory Syncytial Virus mRNA Vaccine(Inventprise) 相关的药物交易

登录后查看更多信息